• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用温和溶解法从大肠杆菌包涵体中回收蛋白质。

Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.

作者信息

Singh Anupam, Upadhyay Vaibhav, Upadhyay Arun Kumar, Singh Surinder Mohan, Panda Amulya Kumar

机构信息

Product Development Cell, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, 110067, India.

出版信息

Microb Cell Fact. 2015 Mar 25;14:41. doi: 10.1186/s12934-015-0222-8.

DOI:10.1186/s12934-015-0222-8
PMID:25889252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4379949/
Abstract

Formation of inclusion bodies in bacterial hosts poses a major challenge for large scale recovery of bioactive proteins. The process of obtaining bioactive protein from inclusion bodies is labor intensive and the yields of recombinant protein are often low. Here we review the developments in the field that are targeted at improving the yield, as well as quality of the recombinant protein by optimizing the individual steps of the process, especially solubilization of the inclusion bodies and refolding of the solubilized protein. Mild solubilization methods have been discussed which are based on the understanding of the fact that protein molecules in inclusion body aggregates have native-like structure. These methods solubilize the inclusion body aggregates while preserving the native-like protein structure. Subsequent protein refolding and purification results in high recovery of bioactive protein. Other parameters which influence the overall recovery of bioactive protein from inclusion bodies have also been discussed. A schematic model describing the utility of mild solubilization methods for high throughput recovery of bioactive protein has also been presented.

摘要

在细菌宿主中形成包涵体对大规模回收生物活性蛋白构成了重大挑战。从包涵体中获得生物活性蛋白的过程劳动强度大,而且重组蛋白的产量往往很低。在这里,我们回顾该领域的进展,这些进展旨在通过优化该过程的各个步骤,特别是包涵体的溶解和溶解蛋白的重折叠,来提高重组蛋白的产量和质量。我们讨论了温和的溶解方法,这些方法基于对包涵体聚集体中的蛋白质分子具有类似天然结构这一事实的理解。这些方法在保留类似天然蛋白质结构的同时溶解包涵体聚集体。随后的蛋白质重折叠和纯化导致生物活性蛋白的高回收率。还讨论了影响从包涵体中整体回收生物活性蛋白的其他参数。还提出了一个描述温和溶解方法用于高通量回收生物活性蛋白的示意图模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca2/4379949/ef3d21ae0f0e/12934_2015_222_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca2/4379949/ef3d21ae0f0e/12934_2015_222_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca2/4379949/ef3d21ae0f0e/12934_2015_222_Fig1_HTML.jpg

相似文献

1
Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.采用温和溶解法从大肠杆菌包涵体中回收蛋白质。
Microb Cell Fact. 2015 Mar 25;14:41. doi: 10.1186/s12934-015-0222-8.
2
Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.以三氟乙醇为增溶剂从细菌包涵体中回收生物活性蛋白。
Microb Cell Fact. 2016 Jun 8;15:100. doi: 10.1186/s12934-016-0504-9.
3
Solubilization and refolding of bacterial inclusion body proteins.细菌包涵体蛋白的溶解与复性
J Biosci Bioeng. 2005 Apr;99(4):303-10. doi: 10.1263/jbb.99.303.
4
Solubilization and Refolding of Inclusion Body Proteins.包涵体蛋白的溶解与复性。
Methods Mol Biol. 2022;2406:371-387. doi: 10.1007/978-1-0716-1859-2_22.
5
Solubilization and refolding of inclusion body proteins.包涵体蛋白的溶解与复性
Methods Mol Biol. 2015;1258:283-91. doi: 10.1007/978-1-4939-2205-5_15.
6
Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in .在 中以“经典包涵体”形式表达的重组蛋白的表达、溶解、复性和最终纯化。
Protein Pept Lett. 2021;28(2):122-130. doi: 10.2174/0929866527999200729182831.
7
A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form.单次冻融循环可高效溶解包涵体蛋白并将其重折叠为生物活性形式。
Microb Cell Fact. 2015 Feb 22;14:24. doi: 10.1186/s12934-015-0208-6.
8
Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.从大肠杆菌包涵体中进行治疗性蛋白质的生物加工。
Adv Biochem Eng Biotechnol. 2003;85:43-93. doi: 10.1007/3-540-36466-8_3.
9
Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process.评估通过体外复性和温和溶解过程从大肠杆菌中回收 scFv 蛋白。
Microb Cell Fact. 2019 Jan 14;18(1):5. doi: 10.1186/s12934-019-1053-9.
10
Comparative study to develop a single method for retrieving wide class of recombinant proteins from classical inclusion bodies.开发从经典包涵体中回收广泛类重组蛋白的单一方法的比较研究。
Appl Microbiol Biotechnol. 2018 Mar;102(5):2363-2377. doi: 10.1007/s00253-018-8754-6. Epub 2018 Jan 31.

引用本文的文献

1
Recovering Immunogenic N Protein from Pellets of Recombinant .从重组菌沉淀中回收具有免疫原性的N蛋白
Vaccines (Basel). 2025 Jul 10;13(7):744. doi: 10.3390/vaccines13070744.
2
SOuLMuSiC, a novel tool for predicting the impact of mutations on protein solubility.SOuLMuSiC,一种预测突变对蛋白质溶解度影响的新型工具。
Sci Rep. 2025 Jul 29;15(1):27531. doi: 10.1038/s41598-025-11326-x.
3
Expression and functional characterization of an anti-CD22 scFv targeting B-cell malignancies.靶向B细胞恶性肿瘤的抗CD22单链抗体片段的表达及功能特性分析

本文引用的文献

1
Investigation on solubilization protocols in the refolding of the thioredoxin TsnC from Xylella fastidiosa by high hydrostatic pressure approach.通过高静水压法对来自桑萎蔫病菌的硫氧还蛋白TsnC进行复性时增溶方案的研究。
Protein Expr Purif. 2015 Feb;106:72-7. doi: 10.1016/j.pep.2014.10.013. Epub 2014 Oct 30.
2
Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein.从大肠杆菌包涵体中重折叠并纯化重组L-天冬酰胺酶,使其成为具有活性的四聚体蛋白。
Front Microbiol. 2014 Sep 15;5:486. doi: 10.3389/fmicb.2014.00486. eCollection 2014.
3
Influence of pH control in the formation of inclusion bodies during production of recombinant sphingomyelinase-D in Escherichia coli.
Res Pharm Sci. 2025 Jun 17;20(3):373-391. doi: 10.4103/RPS.RPS_248_24. eCollection 2025 Jun.
4
Molecular Cloning, Optimization of Expression and Functional Characterization of the Global Transcriptional Regulator MosR (Rv0348) of Mycobacterium tuberculosis.结核分枝杆菌全局转录调节因子MosR(Rv0348)的分子克隆、表达优化及功能表征
Appl Biochem Biotechnol. 2025 Jul 3. doi: 10.1007/s12010-025-05299-w.
5
Interferon Lambda: The Next Frontier in Antiviral Therapy?干扰素λ:抗病毒治疗的新前沿?
Pharmaceuticals (Basel). 2025 May 24;18(6):785. doi: 10.3390/ph18060785.
6
Recovery of mouse growth hormone from E. coli inclusion bodies using a mild solubilisation and repeated freeze-thaw approach.采用温和溶解和反复冻融方法从大肠杆菌包涵体中回收小鼠生长激素。
Mol Biol Rep. 2025 Jun 23;52(1):627. doi: 10.1007/s11033-025-10685-y.
7
Serogrouping and Molecular Characterization of ESBL-Producing Avian Pathogenic from Broilers and Turkeys with Colibacillosis in Algeria.阿尔及利亚患大肠杆菌病的肉鸡和火鸡中产超广谱β-内酰胺酶禽源致病性大肠杆菌的血清型鉴定及分子特征分析
Antibiotics (Basel). 2025 Mar 31;14(4):356. doi: 10.3390/antibiotics14040356.
8
The response surface method enables efficient optimization of induction parameters for the production of bioactive peptides in fed-batch bioreactors using Escherichia coli.响应面法能够有效优化使用大肠杆菌在补料分批生物反应器中生产生物活性肽的诱导参数。
Folia Microbiol (Praha). 2025 Apr 26. doi: 10.1007/s12223-025-01265-5.
9
Asian elephant interferons alpha and beta and their anti-herpes viral activity.亚洲象α干扰素和β干扰素及其抗疱疹病毒活性。
Front Immunol. 2025 Mar 25;16:1533038. doi: 10.3389/fimmu.2025.1533038. eCollection 2025.
10
A novel hybrid approach to overcome defects of CE-SELEX and cell-SELEX in developing aptamers against aspartate β-hydroxylase.一种新型混合方法,用于克服毛细管电泳-指数富集配体系统进化技术(CE-SELEX)和细胞-指数富集配体系统进化技术(cell-SELEX)在开发抗天冬氨酸β-羟化酶适配体方面的缺陷。
Res Pharm Sci. 2025 Feb 20;20(1):65-76. doi: 10.4103/RPS.RPS_134_23. eCollection 2025 Feb.
大肠杆菌中重组鞘磷脂酶-D生产过程中pH控制对包涵体形成的影响。
Microb Cell Fact. 2014 Sep 12;13:137. doi: 10.1186/s12934-014-0137-9.
4
Inclusion bodies: not that bad….包涵体:没那么糟糕……
Front Microbiol. 2014 Feb 14;5:56. doi: 10.3389/fmicb.2014.00056. eCollection 2014.
5
TDP-43 inclusion bodies formed in bacteria are structurally amorphous, non-amyloid and inherently toxic to neuroblastoma cells.在细菌中形成的TDP-43包涵体在结构上是无定形的,非淀粉样的,并且对神经母细胞瘤细胞具有内在毒性。
PLoS One. 2014 Jan 30;9(1):e86720. doi: 10.1371/journal.pone.0086720. eCollection 2014.
6
Localization of protein aggregation in Escherichia coli is governed by diffusion and nucleoid macromolecular crowding effect.蛋白质在大肠杆菌中的定位受扩散和拟核大分子拥挤效应的控制。
PLoS Comput Biol. 2013 Apr;9(4):e1003038. doi: 10.1371/journal.pcbi.1003038. Epub 2013 Apr 25.
7
Active inclusion bodies of acid phosphatase PhoC: aggregation induced by GFP fusion and activities modulated by linker flexibility.酸性磷酸酶 PhoC 的活性包含体:GFP 融合诱导的聚集和连接肽柔性调节的活性。
Microb Cell Fact. 2013 Mar 14;12:25. doi: 10.1186/1475-2859-12-25.
8
A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs.一种用于持续自下而上递送蛋白类药物的纳米结构细菌生物支架。
Nanomedicine (Lond). 2013 Oct;8(10):1587-99. doi: 10.2217/nnm.12.188. Epub 2013 Feb 8.
9
A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.用于预测球状蛋白质中“易于聚集”肽的共识方法。
PLoS One. 2013;8(1):e54175. doi: 10.1371/journal.pone.0054175. Epub 2013 Jan 10.
10
Cooperation between two ClpB isoforms enhances the recovery of the recombinant β-galactosidase from inclusion bodies.两种 ClpB 同工酶之间的合作增强了重组β-半乳糖苷酶从包涵体中的回收。
Biochem Biophys Res Commun. 2012 Oct 5;426(4):596-600. doi: 10.1016/j.bbrc.2012.08.135. Epub 2012 Sep 6.